Skip to content
Review Open access

HALP score in solid tumors: Prognostic value, heterogeneity, and translational considerations

Sep 2026 · Translational Oncology · Vol 73 · 0 citations · 43 references
Medicine

Abstract

Highlights • HALP integrates anemia, nutrition, immunity, and systemic inflammation.• Low HALP is generally linked to poorer outcomes across solid tumors.• Cutoff heterogeneity limits threshold transferability and clinical use.• Prospective validation is required before routine implementation.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.